|
ALS2CR8 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.35469999557247E-08 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.167100E-04 |
| Normal-vs-Stage2 |
2.659000E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.098200E-02 |
| Stage1-vs-Stage2 |
5.321200E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
5.357000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
9.375000E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.38589999998384E-06 |
| Normal-vs-AfricanAmerican |
1.09040000029204E-07 |
| Normal-vs-Asian |
3.27980000003336E-06 |
| Caucasian-vs-AfricanAmerican |
5.549900E-02 |
| Caucasian-vs-Asian |
7.310000E-01 |
| AfricanAmerican-vs-Asian |
1.238290E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.779200E-04 |
| Normal-vs-Female |
2.25560000000069E-05 |
| Male-vs-Female |
2.125400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.616300E-03 |
| Normal-vs-Extreme_Weight |
3.227500E-04 |
| Normal-vs-Obese |
2.090000E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
3.519200E-01 |
| Normal_Weight-vs-Obese |
4.081400E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
9.641200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.717000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.462100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.76170000000453E-05 |
| Normal-vs-Age(81-100Yrs) |
4.239400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.905640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.590550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.197800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.295800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.828600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.832600E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.256000E-01 |
| Normal-vs-Grade 3 |
3.251800E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
3.504000E-01 |
| Grade 2-vs-Grade 4 |
4.256000E-01 |
| Grade 3-vs-Grade 4 |
3.251800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51899999999427E-05 |
| Normal-vs-N1 |
2.834200E-02 |
| N0-vs-N1 |
2.501600E-01 |
|
|
